Tags: cervical cancersickle cellbreast cancerbreast cancer screeningCOVID
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England | STAT+: Incyte’s checkpoint inhibitor staves off disease progression in anal cancer trial - 5 days ago STAT+: Bristol immunotherapy improves responses in lung cancer, setting up Phase 3 study - 5 days ago STAT+: Lung cancer drug from iTeos, GSK shows response, boosting TIGIT as a viable target - 5 days ago STAT+: FDA approves innovative T cell immunotherapy for rare soft-tissue cancer - about 2 months ago | |
| 2 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | ||
| 3 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | ||
| 4 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | STAT+: Can iTeos and GSK solve TIGIT’s troubles? - 7 days ago | |
| 5 | Mike Hennessy Jr, President and CEO Pharmacy Times Pro middleweight boxer. UK/Ireland. | ||
| 6 | Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia | Is a better CAR-T cell therapy option on the horizon? - 2 months ago | |
| 7 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 2 months ago Futile Immunotherapy for Cancer Grows More Common - 9 months ago | |
| 8 | Crystal Phend MedPage Today Contributing editor at MedPage Today. Personal views. | ||
| 9 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | ||
| 10 | <em>The Scientist</em> The Scientist Exploring Life, Inspiring Innovation. |